Eton Pharmaceuticals, Inc. Operating Lease, Payments
Eton Pharmaceuticals, Inc. (ETON) reported Operating Lease, Payments of $97.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:OperatingLeasePayments · last filed 2026-08-13
- Eton Pharmaceuticals, Inc. operating lease, payments for the quarter ending 2026-06-30 was $72.00K, a 227.27% increase year-over-year.
- Eton Pharmaceuticals, Inc. operating lease, payments for the quarter ending 2026-03-31 was $25.00K, a 8.70% increase year-over-year.
- Eton Pharmaceuticals, Inc. operating lease, payments for the quarter ending 2025-12-31 was $0.00, a 100.00% decline year-over-year.
- Eton Pharmaceuticals, Inc. operating lease, payments for the quarter ending 2025-09-30 was $23.00K, a 4.55% increase year-over-year.
- Eton Pharmaceuticals, Inc. operating lease, payments for fiscal 2025 was $68.00K, a 17.24% increase from fiscal 2024.
- Eton Pharmaceuticals, Inc. operating lease, payments for fiscal 2024 was $58.00K, a 34.09% decline from fiscal 2023.
- Eton Pharmaceuticals, Inc. operating lease, payments for fiscal 2023 was $88.00K, a 0.00% change from fiscal 2022.
- Eton Pharmaceuticals, Inc. operating lease, payments for fiscal 2022 was $88.00K, a 6.02% increase from fiscal 2021.
| Period end | Operating Lease, Payments 3 month | Operating Lease, Payments 3 month as first filed | Operating Lease, Payments 6 month | Operating Lease, Payments 9 month | Operating Lease, Payments 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | $72.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $97.00K 10-Q · filed 2026-08-13 | $97.00K derived: sum of 3 quarters · filed 2026-08-13 | $120.00K derived: sum of 4 quarters · filed 2026-08-13 | |
| 2026-03-31 | $25.00K 10-Q · filed 2026-05-14 | $25.00K derived: sum of 2 quarters · filed 2026-05-14 | $48.00K derived: sum of 3 quarters · filed 2026-05-14 | $70.00K derived: sum of 4 quarters · filed 2026-08-13 | |
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-19 | $23.00K derived: sum of 2 quarters · filed 2026-03-19 | $45.00K derived: sum of 3 quarters · filed 2026-08-13 | $68.00K 10-K · filed 2026-03-19 | |
| 2025-09-30 | $23.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $45.00K derived: sum of 2 quarters · filed 2026-08-13 | $68.00K 10-Q · filed 2025-11-06 | $91.00K derived: sum of 4 quarters · filed 2026-08-13 | |
| 2025-06-30 | $22.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $45.00K 10-Q · filed 2026-08-13 | $68.00K derived: sum of 3 quarters · filed 2026-08-13 | $90.00K derived: sum of 4 quarters · filed 2026-08-13 | |
| 2025-03-31 | $23.00K 10-Q · filed 2026-05-14 | $46.00K derived: sum of 2 quarters · filed 2026-05-14 | $68.00K derived: sum of 3 quarters · filed 2026-05-14 | $71.00K derived: sum of 4 quarters · filed 2026-05-14 | |
| 2024-12-31 | $23.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-19 | $45.00K derived: sum of 2 quarters · filed 2026-03-19 | $48.00K derived: sum of 3 quarters · filed 2026-03-19 | $58.00K 10-K · filed 2026-03-19 | |
| 2024-09-30 | $22.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $25.00K derived: sum of 2 quarters · filed 2025-11-06 | $35.00K 10-Q · filed 2025-11-06 | $57.00K derived: sum of 4 quarters · filed 2026-03-19 | |
| 2024-06-30 | $3.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $13.00K 10-Q · filed 2025-08-07 | $35.00K derived: sum of 3 quarters · filed 2026-03-19 | $64.00K derived: sum of 4 quarters · filed 2026-03-19 | |
| 2024-03-31 | $10.00K 10-Q · filed 2025-05-13 | $32.00K derived: sum of 2 quarters · filed 2026-03-19 | $61.00K derived: sum of 3 quarters · filed 2026-03-19 | $76.00K derived: sum of 4 quarters · filed 2026-03-19 | |
| 2023-12-31 | $22.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-19 | $51.00K derived: sum of 2 quarters · filed 2026-03-19 | $66.00K derived: sum of 3 quarters · filed 2026-03-19 | $88.00K 10-K · filed 2026-03-19 | |
| 2023-09-30 | $29.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $44.00K derived: sum of 2 quarters · filed 2024-11-12 | $66.00K 10-Q · filed 2024-11-12 | $88.00K derived: sum of 4 quarters · filed 2025-03-18 | |
| 2023-06-30 | $15.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $37.00K 10-Q · filed 2024-08-08 | $59.00K derived: sum of 3 quarters · filed 2025-03-18 | $81.00K derived: sum of 4 quarters · filed 2025-03-18 | |
| 2023-03-31 | $22.00K 10-Q · filed 2024-05-09 | $19.00K 10-Q · filed 2023-05-11 | $44.00K derived: sum of 2 quarters · filed 2025-03-18 | $66.00K derived: sum of 3 quarters · filed 2025-03-18 | $90.00K derived: sum of 4 quarters · filed 2025-03-18 |
| 2022-12-31 | $22.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-18 | $44.00K derived: sum of 2 quarters · filed 2025-03-18 | $68.00K derived: sum of 3 quarters · filed 2025-03-18 | $88.00K 10-K · filed 2025-03-18 | |
| 2022-09-30 | $22.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $46.00K derived: sum of 2 quarters · filed 2023-11-09 | $66.00K 10-Q · filed 2023-11-09 | $86.00K derived: sum of 4 quarters · filed 2024-03-14 | |
| 2022-06-30 | $24.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | $44.00K 10-Q · filed 2023-08-10 | $64.00K derived: sum of 3 quarters · filed 2024-03-14 | $84.00K derived: sum of 4 quarters · filed 2024-03-14 | |
| 2022-03-31 | $20.00K 10-Q · filed 2023-05-11 | $40.00K derived: sum of 2 quarters · filed 2024-03-14 | $60.00K derived: sum of 3 quarters · filed 2024-03-14 | ||
| 2021-12-31 | $20.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-14 | $40.00K derived: sum of 2 quarters · filed 2024-03-14 | $83.00K 10-K · filed 2024-03-14 | ||
| 2021-09-30 | $20.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-16 | $63.00K 10-Q · filed 2021-11-16 | |||
| 2021-06-30 | $43.00K 10-Q · filed 2021-08-16 | ||||
| 2020-12-31 | $32.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-16 | $66.00K derived: sum of 2 quarters · filed 2022-03-16 | $99.00K derived: sum of 3 quarters · filed 2022-03-16 | $131.00K 10-K · filed 2022-03-16 | |
| 2020-09-30 | $34.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-12 | $67.00K derived: sum of 2 quarters · filed 2020-11-12 | $99.00K 10-Q · filed 2020-11-12 | $129.00K derived: sum of 4 quarters · filed 2021-03-16 | |
| 2020-06-30 | $33.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-12 | $65.00K 10-Q · filed 2020-08-12 | $95.00K derived: sum of 3 quarters · filed 2021-03-16 | $126.00K derived: sum of 4 quarters · filed 2021-03-16 | |
| 2020-03-31 | $32.00K 10-Q · filed 2020-05-14 | $62.00K derived: sum of 2 quarters · filed 2021-03-16 | $93.00K derived: sum of 3 quarters · filed 2021-03-16 | $119.00K derived: sum of 4 quarters · filed 2021-03-16 | |
| 2019-12-31 | $30.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-16 | $61.00K derived: sum of 2 quarters · filed 2021-03-16 | $87.00K derived: sum of 3 quarters · filed 2021-03-16 | $120.00K 10-K · filed 2021-03-16 | |
| 2019-09-30 | $31.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-14 | $57.00K derived: sum of 2 quarters · filed 2019-11-14 | $90.00K 10-Q · filed 2019-11-14 | ||
| 2019-06-30 | $26.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-06 | $59.00K 10-Q · filed 2019-08-06 | |||
| 2019-03-31 | $33.00K 10-Q · filed 2019-05-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Xeris Biopharma Holdings, Inc. (XERS) | United States | $1.632B | -80.10 |
| Stoke Therapeutics, Inc. (STOK) | United States | $1.630B | -9.82 |
| Xencor Inc (XNCR) | United States | $1.776B | -7.33 |
| Rapport Therapeutics, Inc. (RAPP) | United States | $1.623B | -14.56 |
| Septerna, Inc. (SEPN) | United States | $1.783B | -63.01 |
| Syndax Pharmaceuticals Inc (SNDX) | United States | $1.606B | -8.82 |
| ANI PHARMACEUTICALS INC (ANIP) | United States | $1.810B | 18.77 |
| COMPASS Pathways plc (CMPS) | $1.812B | -4.87 | |
| Kailera Therapeutics, Inc. (KLRA) | United States | $1.552B | |
| ANAPTYSBIO, INC (ANAB) | United States | $1.546B | -60.20 |